RIVAROXABAN MYLAN
15MG+20MG TBL FLM 42X15MG+7X20MG
| SÚKL code | 0255367 |
|---|---|
| Name of the product | RIVAROXABAN MYLAN |
| _MA_MEDICATION_DETAIL_INFO_MED_NAME i | RIVAROXABAN MYLAN |
| Supplement | 15MG+20MG TBL FLM 42X15MG+7X20MG |
| Strenght | 15MG+20MG |
| Pharmaceutical form | Film-coated tablet |
| Package | 42X15MG+7X20MG |
| Route | Oral use |
| Wrap type | Blister |
| Legal status | na lékařský předpis |
| Active substance | RIVAROXABAN (RIVAROXABANUM) |
| ATC group | B01AF01 |
| ATC group name | RIVAROXABAN |
Marketing authorisation information
| Registration Number | EU/1/21/1588/055 |
|---|---|
| Type of MA | centralised without orphans |
| MA status | R - active MA/authorised medicinal product |
| MA Holder | Mylan Ireland Limited, Dublin |
| MA Holder country | IRSKO |
cz